Usefulness of stratum corneum analysis for malignancy of the melanocyte system.

Usefulness of stratum corneum analysis for malignancy of the melanocyte system. - Usefulness of stratum corneum analysis for malignancy of the melanocyte system.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048426

Enrollment

Registered

2022-07-31

Start date

2020-06-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

melanoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with primary cutaneous melanoma for whom surgical treatment is decided Healthy individuals without melanoma as controls (patients attending a dermatologist clinic).

Exclusion criteria

Exclusion criteria: Melanoma other than primary skin Melanoma with cutaneous metastases Individuals taking or taking topical medications or supplements that affect melanogenesis, such as anti-inflammatory agents, antioxidants, and steroids, within 3 months. Persons who have experienced contact dermatitis with commercial household cellophane tape

Design outcomes

Primary

Measure	Time frame
To verify the mechanism of carcinogenesis by ultraviolet radiation of skin primary melanoma occurring in exposed areas by melanin ratio (Eumelanin/Pheomelanin) in epidermal stratum corneum.	—

Countries

Japan

Contacts

Public ContactHiroshi Matsunaka

TOKIWA Pharmaceutical Co., Ltd. NOV Academic Research

yumi_murakami@n1.noevir.co.jp08024879141

Outcome results